Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

by Hawraa Issa, Hawraa Issa, Ali H. Eid, Ali H. Eid, Bassam Berry, Vahideh Takhviji, Abbas Khosravi, Sarah Mantash, Rawan Nehme, Rawan Hallal, Hussein Karaki, Kawthar Dhayni, Kawthar Dhayni, Wissam H. Faour, Firas Kobeissy, Ali Nehme, Kazem Zibara
Published 2021-03-01